IRGQ1 Activators
IRGQ1 can initiate a cascade of intracellular events leading to its activation through various pathways. Forskolin is known to directly stimulate adenylate cyclase, which catalyzes the conversion of ATP to cAMP, a secondary messenger with wide-ranging cellular effects. The increase in cAMP levels subsequently activates protein kinase A (PKA), a kinase that can phosphorylate a multitude of proteins, including IRGQ1. Similarly, Isoproterenol functions as a beta-adrenergic agonist, binding to beta receptors that activate G proteins and then adenylate cyclase, again resulting in elevated cAMP levels and PKA activation. This activation of PKA is a common downstream effect shared by other chemicals such as Prostaglandin E2 (PGE2), which binds to its own G protein-coupled receptors, and Glucagon, which also targets its specific receptor to increase cAMP through adenylate cyclase stimulation. Epinephrine follows a comparable route, engaging adrenergic receptors to ultimately enhance the activity of PKA that can act on IRGQ1.
IBMX and Dibutyryl-cAMP affect the cAMP levels by different mechanisms; IBMX inhibits the degradation of cAMP by blocking phosphodiesterases, thus sustaining PKA activity, whereas Dibutyryl-cAMP, a more stable cAMP analog, bypasses the cell's external receptors and directly activates PKA. Phorbol 12-myristate 13-acetate (PMA) represents a different class of activation, directly stimulating protein kinase C (PKC), which can phosphorylate a range of target proteins, potentially including IRGQ1. The activation of IRGQ1 by calcium ionophores such as Ionomycin and A23187 is mediated by the increase of intracellular calcium levels, which activates calcium-dependent protein kinases with possible downstream effects on IRGQ1. Lastly, Anisomycin, although primarily a protein synthesis inhibitor, can activate stress-activated protein kinases such as JNK, which may target and phosphorylate IRGQ1 as part of cellular stress response mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, binds to beta receptors leading to G protein activation and subsequently adenylate cyclase activation. The resulting increase in cAMP levels leads to PKA activation, which may phosphorylate and activate IRGQ1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP. By preventing cAMP degradation, IBMX indirectly maintains high levels of cAMP, which in turn sustains PKA activity. PKA can then phosphorylate and activate IRGQ1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G protein-coupled receptors (EP receptors), leading to adenylate cyclase activation and an increase in cAMP levels. This cascade activates PKA, which can phosphorylate and activate IRGQ1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases such as JNK. Activated JNK has been shown to phosphorylate certain targets that could include IRGQ1 as part of a stress response mechanism. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent kinases such as calmodulin kinase, which may subsequently phosphorylate and activate IRGQ1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide range of target proteins. PKC-mediated phosphorylation of IRGQ1 could lead to its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that directly activates PKA. Activation of PKA could result in phosphorylation and activation of IRGQ1. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which through G protein-coupled receptor mechanisms can activate adenylate cyclase, leading to an increase in cAMP and activation of PKA. PKA may then phosphorylate and activate IRGQ1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that can increase intracellular calcium, potentially leading to activation of calcium/calmodulin-dependent kinases which may phosphorylate and activate IRGQ1. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits cGMP-specific phosphodiesterases, resulting in elevated cGMP levels. Although cGMP is distinct from cAMP, cGMP can cross-activate cAMP pathways in some cells, potentially leading to PKA activation and subsequent phosphorylation and activation of IRGQ1. | ||||||